Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Preserving Patient Access to Compounded Medications Act of 2017
Client: MEDISCA INC · Firm: POLITICAL CAPITAL, LLC
DQSA Oversight HR 2871
Preserving Patient Access to Compounded Medications Act of 2017
Client: MEDISCA INC · Firm: POLITICAL CAPITAL, LLC
DQSA Oversight HR 2871
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
STOKES PHARMACY via POLITICAL CAPITAL, LLC
2026 · second_quarter · Q2
Outsourcing Facility Access and Guidance
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
STOKES PHARMACY via POLITICAL CAPITAL, LLC
2026 · second_quarter · RA
Source: Senate LDA
Preserving Patient Access to Compounded Medications Act of 2017
Client: MEDISCA INC · Firm: POLITICAL CAPITAL, LLC
DQSA Oversight HR 2871
Preserving Patient Access to Compounded Medications Act of 2017
Client: MEDISCA INC · Firm: POLITICAL CAPITAL, LLC
DQSA Oversight HR 2871
Preserving Patient Access to Compounded Medications Act of 2017
Client: MEDISCA INC · Firm: POLITICAL CAPITAL, LLC
DQSA Oversight HR 2871
Preserving Patient Access to Compounded Medications Act of 2017
Client: MEDISCA INC · Firm: POLITICAL CAPITAL, LLC
DQSA Oversight HR 2871
Preserving Patient Access to Compounded Medications Act of 2017
Client: MEDISCA INC · Firm: POLITICAL CAPITAL, LLC
DQSA Oversight HR 2871
Preserving Patient Access to Compounded Medications Act of 2017
Client: MEDISCA INC · Firm: POLITICAL CAPITAL, LLC
DQSA Oversight HR 2871
Preserving Patient Access to Compounded Medications Act of 2017
Client: MEDISCA INC · Firm: POLITICAL CAPITAL, LLC
DQSA Oversight HR 2871
FDA Guidance Documents FDA PCAC Safe Drug Legislation
STOKES PHARMACY via POLITICAL CAPITAL, LLC
2021 · second_quarter · 2T
Compounding pharmacy
Compounding pharmacy
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2021 · second_quarter · 2T
Compounding pharmacy
Compounding pharmacy
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
STOKES PHARMACY via POLITICAL CAPITAL, LLC
2021 · first_quarter · Q1
Compounding pharmacy
Compounding pharmacy
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2021 · first_quarter · Q1
Compounding pharmacy
Compounding pharmacy
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
STOKES PHARMACY via POLITICAL CAPITAL, LLC
2020 · fourth_quarter · Q4
Compounding
Compounding
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2020 · fourth_quarter · Q4
Guidance documents, compounding pharmacy, appropriations language.
Guidance documents, compounding pharmacy, appropriations language.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
STOKES PHARMACY via POLITICAL CAPITAL, LLC
2020 · third_quarter · Q3
Compounding
Compounding
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2020 · third_quarter · Q3
Guidance documents, compounding pharmacy, appropriations language.
Guidance documents, compounding pharmacy, appropriations language.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
STOKES PHARMACY via POLITICAL CAPITAL, LLC
2020 · second_quarter · Q2
Compounding
Compounding
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2020 · second_quarter · Q2
Guidance documents, compounding pharmacy, appropriations language.
Guidance documents, compounding pharmacy, appropriations language.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
STOKES PHARMACY via POLITICAL CAPITAL, LLC
2020 · first_quarter · Q1
Compounding
Compounding
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PINE PHARMACEUTICALS via POLITICAL CAPITAL, LLC
2020 · first_quarter · 1T
Guidance documents, compounding pharmacy, appropriations language.
Guidance documents, compounding pharmacy, appropriations language.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2020 · first_quarter · Q1
Guidance documents, compounding pharmacy, appropriations language.
Guidance documents, compounding pharmacy, appropriations language.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
KRS GLOBAL BIOTECHNOLOGY INC via POLITICAL CAPITAL, LLC
2019 · fourth_quarter · Q4
Compounding
Compounding
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
STOKES PHARMACY via POLITICAL CAPITAL, LLC
2019 · fourth_quarter · Q4
Compounding
Compounding
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PINE PHARMACEUTICALS via POLITICAL CAPITAL, LLC
2019 · fourth_quarter · Q4
Guidance documents, compounding pharmacy, appropriations language.
Guidance documents, compounding pharmacy, appropriations language.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2019 · fourth_quarter · Q4
Guidance documents, compounding pharmacy, appropriations language.
Guidance documents, compounding pharmacy, appropriations language.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
KRS GLOBAL BIOTECHNOLOGY INC via POLITICAL CAPITAL, LLC
2019 · third_quarter · Q3
Compounding
Compounding
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
STOKES PHARMACY via POLITICAL CAPITAL, LLC
2019 · third_quarter · Q3
Compounding
Compounding
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PINE PHARMACEUTICALS via POLITICAL CAPITAL, LLC
2019 · third_quarter · Q3
Guidance documents, compounding pharmacy, appropriations language.
Guidance documents, compounding pharmacy, appropriations language.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2019 · third_quarter · Q3
Guidance documents, compounding pharmacy, appropriations language.
Guidance documents, compounding pharmacy, appropriations language.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
KRS GLOBAL BIOTECHNOLOGY INC via POLITICAL CAPITAL, LLC
2019 · second_quarter · Q2
Compounding
Compounding
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
STOKES PHARMACY via POLITICAL CAPITAL, LLC
2019 · second_quarter · Q2
Compounding
Compounding
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PINE PHARMACEUTICALS via POLITICAL CAPITAL, LLC
2019 · second_quarter · Q2
Guidance documents, compounding pharmacy, appropriations language.
Guidance documents, compounding pharmacy, appropriations language.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2019 · second_quarter · Q2
Guidance documents, compounding pharmacy, appropriations language.
Guidance documents, compounding pharmacy, appropriations language.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
KRS GLOBAL BIOTECHNOLOGY INC via POLITICAL CAPITAL, LLC
2019 · first_quarter · Q1
Compounding
Compounding
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
STOKES PHARMACY via POLITICAL CAPITAL, LLC
2019 · first_quarter · Q1
Compounding
Compounding
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
KRS GLOBAL BIOTECHNOLOGY INC via POLITICAL CAPITAL, LLC
2019 · first_quarter · RR
Guidance documents, compounding pharmacy, appropriations language.
Guidance documents, compounding pharmacy, appropriations language.
STOKES PHARMACY via POLITICAL CAPITAL, LLC
2019 · first_quarter · RR
Guidance documents, compounding pharmacy, appropriations language.
Guidance documents, compounding pharmacy, appropriations language.
PINE PHARMACEUTICALS via POLITICAL CAPITAL, LLC
2019 · first_quarter · Q1
Guidance documents, compounding pharmacy, appropriations language.
Guidance documents, compounding pharmacy, appropriations language.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2019 · first_quarter · Q1
Guidance documents, compounding pharmacy, appropriations language.
Guidance documents, compounding pharmacy, appropriations language.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PINE PHARMACEUTICALS via POLITICAL CAPITAL, LLC
2018 · fourth_quarter · Q4
Outsourcing Facilities HR-2871
Outsourcing Facilities HR-2871
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2018 · fourth_quarter · Q4
Drug Quality Security Act HR-2871
DQSA Oversight HR 2871
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2018 · third_quarter · 3A
DQSA Oversight HR 2871
Drug Quality Security Act HR-2871
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PINE PHARMACEUTICALS via POLITICAL CAPITAL, LLC
2018 · third_quarter · Q3
Outsourcing Facilities HR-2871
Outsourcing Facilities HR-2871
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2018 · third_quarter · Q3
DQSA Oversight HR 2871
Drug Quality Security Act HR-2871
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PINE PHARMACEUTICALS via POLITICAL CAPITAL, LLC
2018 · second_quarter · Q2
Outsourcing Facilities HR-2871
Outsourcing Facilities HR-2871
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2018 · second_quarter · Q2
DQSA Oversight HR 2871
Drug Quality Security Act HR-2871
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2018 · first_quarter · 1A
Drug Quality Security Act HR-2871
DQSA Oversight HR 2871
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PINE PHARMACEUTICALS via POLITICAL CAPITAL, LLC
2018 · first_quarter · Q1
Outsourcing Facilities HR-2871
Outsourcing Facilities HR-2871
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2018 · first_quarter · Q1
DQSA Oversight HR 2871
Drug Quality Security Act HR-2871
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PINE PHARMACEUTICALS via POLITICAL CAPITAL, LLC
2017 · fourth_quarter · Q4
Outsourcing Facilities HR-2871
Outsourcing Facilities HR-2871
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2017 · fourth_quarter · Q4
Drug Quality Security Act HR-2871
DQSA Oversight HR 2871
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PINE PHARMACEUTICALS via POLITICAL CAPITAL, LLC
2017 · third_quarter · 3A
Outsourcing Facilities HR-2871
Outsourcing Facilities HR-2871
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2017 · third_quarter · Q3
Drug Quality Security Act HR-2871
DQSA Oversight HR 2871
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PINE PHARMACEUTICALS via POLITICAL CAPITAL, LLC
2017 · third_quarter · RR
Drug Quality Security Act HR-2871
Drug Quality Security Act HR-2871
MEDISCA INC via POLITICAL CAPITAL, LLC
2017 · second_quarter · Q2
DQSA Oversight HR 2871
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDISCA INC via POLITICAL CAPITAL, LLC
2017 · first_quarter · Q1
DQSA Oversight
Filing targets: Food & Drug Administration (FDA)
MEDISCA INC via POLITICAL CAPITAL, LLC
2017 · first_quarter · RR
Drug Quality Security ACT Drug Spending Cost Opioid Issues
Drug Quality Security ACT Drug Spending Cost Opioid Issues
Drug Quality Security ACT Drug Spending Cost Opioid Issues
Drug Quality Security ACT Drug Spending Cost Opioid Issues